Titan Pharmaceuticals, Inc. - stock earnings
TTNP Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -338000 USD | 4000 USD |
2023Q2 | -1.6 million USD | 1000 USD |
2023Q1 | -1.7 million USD | 98000 USD |
2022Q4 | -2.6 million USD | 51000 USD |
2022Q3 | -2.6 million USD | 4000 USD |
2022Q2 | -2.5 million USD | 150000 USD |
2022Q1 | -2.5 million USD | 192000 USD |
2021Q4 | -2.5 million USD | 135000 USD |
2021Q3 | -1.9 million USD | 264000 USD |
2021Q2 | -1.7 million USD | 445000 USD |
2021Q1 | -2.6 million USD | 682000 USD |
2020Q4 | -3.1 million USD | 1.1 million USD |
2020Q3 | -4.9 million USD | 1.1 million USD |
2020Q2 | -4.6 million USD | 1.3 million USD |
2020Q1 | -5.6 million USD | 1.3 million USD |
2019Q4 | -3.9 million USD | 1.2 million USD |
2019Q3 | -2.8 million USD | 947000 USD |
2019Q2 | -5.2 million USD | 502000 USD |
2019Q1 | -3.5 million USD | 530000 USD |
2018Q4 | -3.5 million USD | 530000 USD |
2018Q3 | -2.0 million USD | 1.7 million USD |
2018Q2 | -869000 USD | 2.7 million USD |
2018Q1 | -3.7 million USD | 58000 USD |
2017Q4 | -3.7 million USD | 58000 USD |
2017Q3 | -4.2 million USD | 40000 USD |
2017Q2 | -3.5 million USD | 77000 USD |
2017Q1 | -3.0 million USD | 40000 USD |
2016Q4 | -2.3 million USD | 35000 USD |
2016Q3 | -2.6 million USD | 26000 USD |
2016Q2 | 11.9 million USD | 15.0 million USD |
2016Q1 | -1.8 million USD | ? USD |
2015Q4 | -2.3 million USD | 1.7 million USD |
2015Q3 | -1.8 million USD | 760000 USD |
2015Q2 | -2.3 million USD | 760000 USD |
2015Q1 | -4.9 million USD | 911000 USD |
2014Q4 | -473000 USD | 912000 USD |
2014Q3 | 716000 USD | 911000 USD |
2014Q2 | -842000 USD | 911000 USD |
2014Q1 | -1.8 million USD | 911000 USD |
2013Q4 | -209000 USD | 911000 USD |
2013Q3 | -1.1 million USD | 2.2 million USD |
2013Q2 | 5.1 million USD | 2.2 million USD |
2013Q1 | 6.0 million USD | 5.2 million USD |
2012Q4 | -279000 USD | 3.3 million USD |
2012Q3 | -8.0 million USD | 1.2 million USD |
2012Q2 | -1.7 million USD | 1.4 million USD |
2012Q1 | -5.2 million USD | 1.3 million USD |
2011Q4 | -2.9 million USD | 1.4 million USD |
2011Q3 | -804000 USD | 1.0 million USD |
2011Q2 | -7.0 million USD | 695000 USD |
2011Q1 | -4.5 million USD | 948000 USD |
2010Q4 | -4.3 million USD | 2.7 million USD |
2010Q3 | -384000 USD | 3.6 million USD |
2010Q2 | -1.8 million USD | 1.3 million USD |
2010Q1 | -305000 USD | 2.4 million USD |
2009Q4 | -1.5 million USD | 27000 USD |
2009Q3 | -1.6 million USD | 29000 USD |
2009Q2 | -1.7 million USD | 29000 USD |
2009Q1 | -1.1 million USD | 23000 USD |
2008Q4 | -6.1 million USD | 73000 USD |
2008Q3 | -5.9 million USD | 12000 USD |
2008Q2 | -7.7 million USD | 12000 USD |
2008Q1 | -5.7 million USD | 61000 USD |
2007Q4 | -6.2 million USD | 12000 USD |
2007Q3 | -4.3 million USD | 12000 USD |
2007Q2 | -3.5 million USD | 12000 USD |
2007Q1 | -3.6 million USD | 29000 USD |
2006Q4 | -3.3 million USD | 29000 USD |
2006Q3 | -4.3 million USD | 1000 USD |
2006Q2 | -3.4 million USD | 1000 USD |
2006Q1 | -4.7 million USD | 1000 USD |
2005Q4 | -4.0 million USD | 61000 USD |
2005Q3 | -6.4 million USD | 1000 USD |
2005Q2 | -5.7 million USD | 13000 USD |
2005Q1 | -6.3 million USD | 14000 USD |
2004Q4 | -7.8 million USD | 30000 USD |
2004Q3 | -6.3 million USD | ? USD |
2004Q2 | -5.6 million USD | 2000 USD |
2004Q1 | -6.4 million USD | 1000 USD |
2003Q4 | -10.5 million USD | 61000 USD |
2003Q3 | -6.2 million USD | 2000 USD |
2003Q2 | -6.7 million USD | 2000 USD |
2003Q1 | -6.5 million USD | 26000 USD |
2002Q4 | -8.9 million USD | 236000 USD |
2002Q3 | -7.3 million USD | 158000 USD |
2002Q2 | -7.0 million USD | 151000 USD |
2002Q1 | -5.0 million USD | 2.3 million USD |
2001Q4 | -6.3 million USD | 589000 USD |
2001Q3 | -4.8 million USD | 530000 USD |
2001Q2 | -1.8 million USD | 2.9 million USD |
2001Q1 | -4.0 million USD | 569000 USD |
2000Q4 | -4.0 million USD | 569000 USD |
2000Q3 | -8.7 million USD | 695000 USD |
2000Q2 | -2.4 million USD | 281000 USD |
2000Q1 | -3.6 million USD | 335000 USD |
1999Q4 | -2.9 million USD | 200000 USD |
1999Q3 | -2.4 million USD | 100000 USD |
1999Q2 | -3.1 million USD | 100000 USD |
1999Q1 | -2.8 million USD | 100000 USD |
1998Q4 | -3.2 million USD | ? USD |
1998Q3 | -2.8 million USD | 100000 USD |
1998Q2 | -2.2 million USD | 100000 USD |
1998Q1 | -2.4 million USD | 100000 USD |
1997Q4 | 13.4 million USD | 17.4 million USD |
1997Q3 | -3.8 million USD | 100000 USD |
1997Q2 | 4.2 million USD | 100000 USD |
1997Q1 | -13.2 million USD | 100000 USD |
1996Q4 | -4.0 million USD | 200000 USD |
1996Q3 | -2.8 million USD | 100000 USD |
1996Q2 | -2.7 million USD | 100000 USD |
1996Q1 | -3.4 million USD | 100000 USD |
1995Q4 | -3.0 million USD | ? USD |
1995Q3 | -2.9 million USD | 100000 USD |
1995Q2 | -2.9 million USD | 100000 USD |
1995Q1 | -2.9 million USD | 100000 USD |
TTNP Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -6.2 million USD | 52000 USD |
2022 | -10.2 million USD | 60000 USD |
2021 | -8.1 million USD | 1.5 million USD |
2020 | -20.7 million USD | 4.8 million USD |
2019 | -16.1 million USD | 3.6 million USD |
2018 | -9.0 million USD | 5.9 million USD |
2017 | -14.3 million USD | 215000 USD |
2016 | 5.1 million USD | 15.1 million USD |
2015 | -11.3 million USD | 1.7 million USD |
2014 | -2.4 million USD | 3.6 million USD |
2013 | 9.7 million USD | 10.5 million USD |
2012 | -15.2 million USD | 7.1 million USD |
2011 | -15.2 million USD | 4.1 million USD |
2010 | -6.8 million USD | 10.1 million USD |
2009 | -5.9 million USD | 79000 USD |
2008 | -25.4 million USD | 70000 USD |
2007 | -17.6 million USD | 24000 USD |
2006 | -15.7 million USD | 32000 USD |
2005 | -22.5 million USD | 89000 USD |
2004 | -26.0 million USD | 31000 USD |
2003 | -29.9 million USD | 89000 USD |
2002 | -28.2 million USD | 2.9 million USD |
2001 | -17.5 million USD | 4.6 million USD |
2000 | -18.8 million USD | 1.9 million USD |
1999 | -11.3 million USD | 300000 USD |
1998 | -10.6 million USD | 100000 USD |
1997 | 600000 USD | 17.5 million USD |
1996 | -12.9 million USD | 300000 USD |
1995 | -11.7 million USD | 100000 USD |
TTNP
Price: $6.88
52 week price:
Earnings Per Share: -7.41 USD
P/E Ratio: -0.88
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 35000
Ebitda: -4.0 millionMarket Capitalization: 6.6 million